The development of vaginal microbicides for the prevention of HIV transmission
- PMID: 15916473
- PMCID: PMC1140953
- DOI: 10.1371/journal.pmed.0020142
The development of vaginal microbicides for the prevention of HIV transmission
Abstract
Given that we still do not have an effective vaccine against HIV, the development of novel biomedical methods for preventing HIV transmission remains a top priority in controlling the HIV pandemic.
Conflict of interest statement
Figures


Similar articles
-
Specific microbicides in the prevention of HIV infection.J Intern Med. 2011 Dec;270(6):509-19. doi: 10.1111/j.1365-2796.2011.02454.x. Epub 2011 Oct 27. J Intern Med. 2011. PMID: 21917029 Review.
-
Microbicides: putting women in control.WORLD. 1998 Sep;(89):4-5. WORLD. 1998. PMID: 11365770
-
Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines.Antiviral Res. 2010 Dec;88 Suppl 1:S55-66. doi: 10.1016/j.antiviral.2010.09.006. Antiviral Res. 2010. PMID: 21109069
-
Trials of two microbicides to be launched in Africa.BMJ. 2004 Apr 3;328(7443):786. doi: 10.1136/bmj.328.7443.786. BMJ. 2004. PMID: 15070623 Free PMC article. No abstract available.
-
Microbicides to prevent HIV transmission: overcoming obstacles to chemical barrier protection.J Infect Dis. 2006 Jan 1;193(1):36-44. doi: 10.1086/499163. Epub 2005 Nov 17. J Infect Dis. 2006. PMID: 16323129 Review.
Cited by
-
Comparative biophysical properties of tenofovir-loaded, thiolated and nonthiolated chitosan nanoparticles intended for HIV prevention.Nanomedicine (Lond). 2014 Aug;9(11):1595-612. doi: 10.2217/nnm.13.136. Epub 2014 Jan 10. Nanomedicine (Lond). 2014. PMID: 24405490 Free PMC article.
-
Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs.Cell Mol Life Sci. 2015 Feb;72(3):469-503. doi: 10.1007/s00018-014-1756-3. Epub 2014 Oct 17. Cell Mol Life Sci. 2015. PMID: 25323132 Free PMC article. Review.
-
The future role of rectal and vaginal microbicides to prevent HIV infection in heterosexual populations: implications for product development and prevention.Sex Transm Infect. 2011 Dec;87(7):646-53. doi: 10.1136/sextrans-2011-050184. Sex Transm Infect. 2011. PMID: 22110117 Free PMC article.
-
A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infections.AAPS PharmSciTech. 2008;9(2):505-20. doi: 10.1208/s12249-008-9073-5. Epub 2008 Apr 2. AAPS PharmSciTech. 2008. PMID: 18431651 Free PMC article. Review.
-
Deletion of the highly conserved N-glycan at Asn260 of HIV-1 gp120 affects folding and lysosomal degradation of gp120, and results in loss of viral infectivity.PLoS One. 2014 Jun 26;9(6):e101181. doi: 10.1371/journal.pone.0101181. eCollection 2014. PLoS One. 2014. PMID: 24967714 Free PMC article.
References
-
- Horton R. AIDS: The elusive vaccine. New York Rev Books. 2003 September 23;51(14):53–58.
-
- Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev. 2002;2002:CD003255. - PubMed
-
- Hicks DR, Martin LS, Getchell JP, Heath JL, Francis DP, et al. Inactivation of HTLV-III/LAV-infected cultures of normal human lymphocytes by nonoxynol-9 in vitro. Lancet. 1985;2:1422–1423. - PubMed
-
- Miller CJ, Alexander NJ, Gettie A, Hendrickx AG, Marx PA. The effect of contraceptives containing nonoxynol-9 on the genital transmission of simian immunodeficiency virus in rhesus macaques. Fertil Steril. 1992;57:1126–1128. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical